Sorrento Therapeutics, Inc.

LSE:0L85 Stock Report

Market Cap: US$66.3m

Sorrento Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0L85?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20,0000.00368%
Institutions3,387,2290.623%
Individual Insiders4,697,2610.864%
General Public535,608,48298.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.


Top Shareholders

Top 14 shareholders own 1.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.84%
Henry Ji
4,577,498US$558.0k0%no data
0.57%
Norges Bank Investment Management
3,124,932US$380.9k0%no data
0.021%
Jaisim Shah
112,633US$13.7k0%no data
0.0057%
SlateStone Wealth LLC
30,866US$3.8k0%no data
0.0028%
The Huntington Trust Company, National Association
15,001US$1.8k-6.25%no data
0.00092%
Yue Wu
5,000US$609.80%no data
0.00066%
Ogorek Wealth Management, LLC
3,600US$437.40%no data
0.00064%
Guggenheim Partners, LLC
3,481US$424.20%no data
0.00058%
AlphaMark Advisors, LLC
3,135US$384.40%no data
0.00039%
Dorman Followwill
2,130US$258.50%no data
0.00022%
Highlander Capital Management LLC
1,200US$145.80%no data
0.00005%
Russell Investment Management, LLC
266US$33.10%no data
0.00004%
Trust Company of Vermont
204US$26.50%no data
0.00002%
Fusion Investment Advisors LLC
100US$13.30%no data